The adult hair follicle (HF) is one of the only adult mammalian tissues capable of scarless regeneration. This process relies entirely on the presence of epithelial stem/progenitor cells residing within the HF bulge and germ which give rise to keratinocytes that constitute the HF structure and hair fibre.
| INTRODUCTION
The adult hair follicle (HF) is one of the only adult mammalian tissues capable of scarless regeneration. This process relies entirely on the presence of epithelial stem/progenitor cells residing within the HF bulge and germ which give rise to keratinocytes that constitute the HF structure and hair fibre. [1] Of equal importance are dermal papilla (DP) cells, specialized mesenchymal cells that sit directly apposed to the HF germ in the telogen (resting) follicle. Transplantation of DP cells into non-hairy skin results in induction of epithelial cells and de novo formation of HFs [2, 3] ; in contrast, destruction of the DP renders the telogen HF incapable of initiating anagen growth [S1] . Thus, the mesenchyme serves as an instructive niche modulating the activation states of epithelial progenitors and ultimately orchestrating the regenerative process.
For decades, researchers have been fascinated by the unique plasticity exhibited within the HF mesenchyme. Pioneering studies by Oliver [4,5S2] showed that vibrissae follicles amputated at different levels exhibited varied regenerative responses, such that subsequent HF regeneration only occurred when proximal connective tissue sheath (CTS) remained intact. [4] This work suggested that (i) functional distinctions exist within the CTS and (ii) proximal CTS cells are plastic and harbour the capacity to assume an inductive DP phenotype.
Intriguingly, mesenchymal cells comprising the inductive DP and CTS undergo significant cell loss during catagen and subsequent expansion at anagen, yet mitotic activity is negligible within the DP, [6] begging the question: Does the CTS harbour a stem/progenitor cell that serves to populate the HF mesenchyme?
| HFDSCS RESIDE IN THE PROXIMAL CTS AND GENERATE BONA FIDE DP CELLS
Building on this, we discovered that the proximal CTS of anagen follicles contains self-renewing, bipotent hair follicle dermal stem cells (hfDSCs)
that replenish cells within each functionally distinct mesenchymal compartment (DP and entire CTS). [7] Throughout catagen, when the niche is extensively remodeled through carefully orchestrated cell death, hfDSCs are selectively maintained and redistributed to surround the DP during telogen (Figure 1 ). With each new cycle, these few remaining hfDSCs are activated to proliferate generating hundreds of new progeny within each HF. Importantly, at least a subset of hfDSCs labelled in the first week of life, persist 24 months later (Shin, Rahmani and Biernaskie, unpublished data), demonstrating their long-term selfrenewal and regenerative capacity over successive HF cycles. [7] A most intriguing observation was seen in the dynamic nature of hfDSCs within their niche and the active migration of their progeny into the DP where they acquire characteristic of definitive DP cells including versican, ITGA9, noggin and LEF1 expression, whilst concomitantly downregulating features associated with CTS such as αSMA expression. [7] Are these hfDSC-derived DP cells functionally distinct from native DP cells? Functional data suggest they are equivalent as isolated hfDSCs (aSMA dsRed+ve ) are able to induce de novo HF formation when combined with epithelial cells [7] and transplantation of dissected CTS cells is able to reconstitute a competent DP. [8] Does dysregulation of hfDSCs impact the definitive DP cells? Certainly, depletion of hfDSCs interrupted HF regeneration [7] and modified the morphology of subsequent anagen follicles, suggesting that hfDSCs serve as a reservoir of inductive cells that modulate DP number according to external stimuli (ie, hormonal surge during pubertal maturation). These molecular triggers are not known. Notably, the functional consequences of hfDSC ablation are difficult to discern as phenotypic changes could be attributed to disruption of the DP or alternatively the CTS.
| ALTERNATIVE FUNCTIONS OF HFDSCS AND THE CONNECTIVE TISSUE SHEATH
The CTS wraps the outside of each HF and is directly apposed to the migrating keratinocyte progenitors comprising the outer root sheath. Previous studies [4,6,8,9,S3] suggested that proximal CTS cells surrounding the bulb retain considerable plasticity and at least some could replace the DP. In vivo fate mapping confirmed this work,
showing that the CTS is derived entirely from hfDSCs. [7] However, This is intriguing given that resident macrophages decorate the CTS throughout the hair cycle. [10] We hypothesize that hfDSCs maintain the CTS to provide a contiguous physical barrier between the regenerating/degenerating HF and the continuously surveying monocytelineage cells within the interfollicular dermis, thereby preserving its "immune privilege". [11] Related to this is the extensive network of 
| A role in human Hair Follicles?
It remains unknown as to whether hfDSCs exist in human HFs. Unlike the rodent CTS, human follicles contain a multilayered CTS, possibly suggesting the existence of an expanded hfDSC pool. Human terminal follicles undergo anagen growth periods lasting several months to years in duration. Maintenance of this extended activity within the DP may F I G U R E 1 Dynamic reorganization of the hfDSC niche and potential future clinical applications. Schematic depicting the location of hfDSCs in telogen and anagen hair follicles, highlighting their dynamic ability to reorganize within the changing niche over the course of the hair follicle cycle. hfDSCs can be isolated in vitro and generate self-renewing spherical colonies F I G U R E 2 hfDSC progeny exhibit extensive connectivity within the DP Representative image of an anagen hair follicle from αSMACreER T2 :ROSA YFP which labels hfDSCs and their progeny.
Bar=100 μm require greater extrafollicular regulation which would be mediated by hfDSCs. Similarly, immune barrier function around the follicle or promoting the migration of ORS cells in human follicles may also be exaggerated in human skin. Indeed, the success of transplanted CTS cells to initiate human HF formation could be ascribed to their innate capacity to reform the inductive DP, but also to rapidly re-establish a mesenchymal barrier to preserve the viability of the DP and subsequent HF.
| HFDSCS CONTRIBUTE TO FUNCTIONAL HETEROGENEITY WITHIN THE DP
Although assumed to be a homogenous population of inductive cells, there are discrete regional differences in gene expression and ECM deposition within the DP, [7, [12] [13] [14] suggesting there is far greater functional complexity than previously thought. For example, prominin-1 (cd133) initially shows robust expression in the dorsal DP cells, with dynamic changes in expression as the cycle progresses [13,S5] . We suspect that this could be a reflection of earlier expression in definitive DP cells with subsequent expression in supplementary hfDSC-derived DP cells that are recruited as anagen proceeds. Indeed, recruitment of hfDSC progeny into and emigration out of the DP underscore the dynamic nature and cellular diversity within the DP, but the functional significance of this remains unclear. One suggestion is that follicles can undergo morphological switching and recruitment of new cells serves to increase the overall size of the DP, and consequently the size/type of hair that is generated. [15, 16] hfDSCs appear to act as an endogenous reservoir for new DP cells, thereby enabling expansion of the DP when needed. Indeed, deletion of hfDSCs blocks recruitment of new cells into DP of zigzag HFs and prevents hair type switching.
How hfDSCs are activated and instructed to acquire DP or CTS fates remain unknown. Further work will need to address the functional significance of these regional heterogeneities within the DP and the significance across the hair cycle.
| Does Sox2 play a role in maintaining hfDSC plasticity?
It is well documented that the HF mesenchyme exclusively expresses the stem cell-associated transcription factor Sox2 [7,17,S6] .
Although studies have suggested that Sox2 is necessary for hair follicle induction, [13] a more recent conditional knockout study has shown that Sox2 is not essential for HF morphogenesis. [12] When adult Sox2 + hfDSCs are isolated and grown in vitro, we observe a rapid loss of Sox2 expression over time, yet retain at least partial inductive function [18] which is sustained for several passages. Is Sox2 an intrinsic property of hfDSCs or is it environmentally regulated?
We surmise that Sox2 expression is a consequence of residence within the HF niche. In our view, Sox2 + cells are required for induction, and Sox2 is coincident with an inductive phenotype, but Sox2 protein is not necessary for induction. The fact that (i) hfDSCs and their progeny in the DP (but not in the differentiated distal CTS) retain Sox2 expression and (ii) hfDSC progeny in the DP are able to re-enter the hfDSC pool following catagen suggests that Sox2 may serve to maintain this plasticity (ie, self-renewal, bipotency).
Further discussion for the role of Sox2 in the skin and HF can be found elsewhere. [19] 
| Who and what are skin-derived precursors (SKPs)?
SKPs were first characterized as a subset of dermal cells that exhibited self-renewal and clonal colony formation when exposed to fibroblast growth factor (FGF) and could generate both neural and mesodermal progeny when provided with permissive differentiation conditions in vitro [20,21,S7-9] . SKPs can be derived from both hairy and non-hairbearing skin [22,S8] , suggesting that there are multiple FGF-responsive progenitor niches within the dermis. Thus, SKPs are a cell culture phenomenon and spherical colony formation can arise from multiple origins. Unfortunately, this has led to the erroneous assumption that all SKPs are functionally equivalent; however, in vitro colony formation does not equal stem cell function.
Based on their heterogeneity, however, functions previously attributed to SKPs such as Schwann cell differentiation capacity [S9] have been re-examined. It was found that glial differentiation capacity is shared by Sox2-expressing dermal progenitors residing in either HF mesenchyme [S10-11] and presumptive glia cells associated with nerve terminals, both of which are capable of sphere formation in FGF [S12-14] and can myelinate axons. In contrast, however, the inductive capacity exhibited by isolated Sox2-expressing hfDSCs is entirely unique and cannot be replicated by dermal progenitors originating from outside the HF. [13, 14, 17] We propose that the term "SKP" should be discarded, in favour of specific functional definitions for each progenitor population supported by unique prospective identifiers, in vivo genetic lineage tracing and in vivo functional assays to verify true differentiation capacity.
We have attempted to do this with the HF mesenchyme which we showed are a primary cell of origin for SKPs [7,S15] and when prospectively isolated are enriched for serial colony formation and in vitro selfrenewal. There are unique functional parallels between hfDSCs and bulk cultured SKPs. Both are able to reconstitute the HF mesenchyme and generate interfollicular dermal fibroblasts [17] following transplantation. Finally, fate mapping of hfDSCs at a clonal level showed their bipotency and highlighted an absence of functional derivatives beyond the dermal lineage within the normal skin.
That said SKPs (and the dermal progenitor sphere-forming assay)
are not without value. Remarkably, rodent SKPs expanded as spherical (non-adherent) colonies remain capable of inducing de novo HF morphogenesis even following multiple passages, when combined with neonatal epithelial cells [17,S16] which is in contrast to monolayer cultures of DP cells. [23, 24] Thus, aggregate expansion may have important functional significance. Moreover, in adult human skin, where hfDSCs have yet to be identified, the SKPs sphere-forming assay offers an efficient surrogate strategy to study/develop biomarkers of hfDSCs from human skin.
| FUTURE CLINICAL PERSPECTIVES

| Endogenous mobilization of hfDSCs to repair injured skin and/or restoration of hair growth
Hair 
| Autologous transplantation of isolated hfDSCs/ SKPs
The clinical potential of hfDSCs lies in their ability to be isolated and expanded in vitro, whilst maintaining their capacity to generate various dermal/mesenchymal subtypes. As previously hypothesized, their greatest therapeutic value lies in their potential to regenerate neodermis following skin wounding. [25] Several recent studies have defined distinct dermal lineages comprised within the dermis and demonstrated their divergent contributions during wound healing and scarring [26,S17-19] . Indeed, modifying this innate response to injury, or supplementing wounds with upper papillary dermal fibroblasts that are competent to participate in new HF formation, such as hfDSCs, [17] may be an attractive avenue to improve outcomes after severe skin injury ( Figure 3 ).
Along these lines, cultured DP cells have been used to generate neodermis in composite skin [27] providing sustained epidermal progenitor numbers, increased vascularity and graft survival [S20-21] . Similarly, fibroblasts seeded within collagen sponges inhibited wound contraction by blocking host fibroblast infiltration and promoting apoptosis of myofibroblasts 28,S22] . Transplantation of SKPs to chronic wounds improved vascular regeneration and overall wound outcome [29,S23] . After transplant to excision wounds, SKPs fill the cavity generating neodermal tissue. [17] Interestingly, human SKPs are poorly immunogenic and capable of modulating the allogeneic immune response, [30] making them an interesting candidate for autologous cell replacement therapies or as an adjunct to allogeneic cell transplantations. We suspect that hfDSCs/SKPs may be an appropriate adjunct to improve dermal restoration within split-thickness skin grafts, a common therapy for severe wounds plagued by poor functional outcome. Indeed, given their capacity to induce HF morphogenesis when allowed to interact with competent epithelial cells, [17] inclusion of hfDSCs/SKPs within engineered skin constructs might also enable formation of new appendages. Before this can be realized, it must be determined whether human hfDSCs exist in adult human skin, and most importantly, whether they are able to initiate HF morphogenesis with adult human epithelial cells. To do this, reliable markers to prospectively isolate hfDSCs from human skin and to define in vitro conditions that permit sustained expansion whilst retaining their dermal multipotency and inductive function will need to be developed before this therapeutic potential can be realized. Finally, several studies suggest that aged human SKPs exhibit limited self-renewal due to a tendency for senescence [S24-26] . Future pharmacologic interventions may be required to prevent or awaken age-related dormancy of hfDSCs in order to preserve overall skin function and/or maintain their therapeutic potential.
F I G U R E 3
Potential therapeutic applications of hfDSCs in wound healing (A) Schematic showing transplantation of SKPs to repopulate miniaturized follicles, to rejuvenate HF growth. Development of new drugs to stimulate proliferation of hfDSCs may enable increase recruitment into the DP to maintain or restore cell numbers within the DP of miniaturized follicles. (B) SKPs can also be transplanted to repopulate full thickness wounds in chronic or acute wounds. Drugs targeting hfDSCs could be developed to mobilize hfDSCs for recruitment into wounds to promote improved healing
| CONCLUSIONS
The identification of hfDSCs provides a cellular target that may be exploited to replenish or better maintain this inductive population that may be compromised by advanced age or disease. However, more work will be required to better understand the factors that regulate hfDSC behaviour, in normal, aged and pathological skin conditions.
Certainly, fate mapping experiments examining the role of hfDSCs in wound healing will be essential towards understanding their endogenous function and reparative potential. Elucidating cell surface markers in human hfDSCs will be an important step towards their future clinical use. Finally, robust bioprocess for isolation of hfDSCs and expansion of SKPs in vitro must be developed in order to enable successful clinical translation of autologous transplantation therapies.
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